Dáil Éireann Debate, Tuesday - 21 February 2017
465. Deputy Andrew Doyle asked the Minister for Health if a review will be carried out of phenyllcetonuria products on the long-term illness card that have been assessed and are waiting to be assessed; when the products currently waiting to be assessed will be assessed by the HSE; if consultations will take place with persons in need regarding the products available; and if he will make a statement on the matter. [8486/17]
View answer478. Deputy Andrew Doyle asked the Minister for Health the long-term illness card budget spend on PKU products year on year; the person or body responsible for maintaining the list of PKU products; the frequency with which they meet and the criteria used in the assessment of new products for inclusion; and if he will make a statement on the matter. [8598/17]
View answerI propose to take Questions Nos. 465 and 478 together.
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply.
